CNO Stock Analysis: Buy, Sell, or Hold?
CNO - CNO Financial Group, Inc.
$47.75
0.93 (1.99%)
▲
5d:
+4.53%
30d:
+9.44%
90d:
+10.74%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Apr 30, 2026
0d
Get Alerted When CNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CNO is fairly valued with market pricing in 1.4% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: CNO is fairly valued with market pricing in 1.4% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$65.46
Based on 7.9% avg growth
INTRINSIC VALUE TODAY
$40.65
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNO is currently trading at $47.75, which is considered extended relative to its 30-day fair value range of $43.12 to $46.11. The stock's valuation (Forward PE: 9.5) is in line with its historical norms (9.1). At these levels, the market is pricing in 1.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CNO is in a uptrend. The price is approaching resistance at $47.95. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CNO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CNO is in a uptrend. The price is approaching resistance at $47.95. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CNO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$43.12 -
$46.11
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
58.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($47.50)
- NEUTRAL: Market pricing in 1.4% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$43.12 -
$46.11
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$45.08
Resistance Level
$47.95
Current Trend
Uptrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.48
Wall Street Target
$47.50
(+1.5%)
Revenue Growth (YoY)
2.5%
Earnings Growth (YoY)
85.7%
Profit Margin
5.4%
Valuation Premium vs History
+1.4% premium
PE vs Historical
9.5 vs 9.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.4%
(market-implied from PE analysis)
1-Year Target
$47.48
(+1%)
2-Year Target
$48.14
(+3%)
3-Year Target
$48.81
(+4%)
3-Yr Target (if PE normalizes)
(PE: 9→9)
PE COMPRESSION
$46.85
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 11.7%)
$151.96
(+225%)
Base:
(SPY PE: 9.5, Growth: 11.7%)
$65.29
(+39%)
Bear:
(PE: 8.1, Growth: 11.7%)
$55.49
(+19%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 19.03 | Current EPS (TTM): $2.48
Bull Case
$103.36
(+121%)
Analyst growth 99.1%, PE expands to 20.9
Base Case
$93.96
(+101%)
Market implied 99.1%, PE stable at 19.0
Bear Case
$32.09
(-32%)
Severe decline -20.0%, PE contracts to 16.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 18, 2026 11:28 AM ET
Data refreshes hourly during market hours. Next update: 12:28 PM
Data refreshes hourly during market hours. Next update: 12:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Scott L Goldberg
SELL
11060 shares
2026-03-19
Gary C Bhojwani
SELL
43021 shares
2026-02-18
Matthew J Zimpfer
SELL
33800 shares
2026-02-18
Top Rated Insurance - Life Stocks
Top-rated stocks in Insurance - Life by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MET
MetLife Inc |
STRONG BUY
16 analysts |
$91 | 59 HOLD |
|
UNM
Unum Group |
BUY
12 analysts |
$97 | 61 BUY |
|
ABL
Abacus Life Inc. |
STRONG BUY
5 analysts |
$14 | 58 HOLD |
|
MFC
Manulife Financial Corp |
BUY
13 analysts |
$35 | 51 HOLD |
|
GL
Globe Life Inc |
BUY
10 analysts |
$175 | 58 HOLD |
